نتایج جستجو برای: ایمپلنت dio

تعداد نتایج: 2557  

Journal: :Nutrition & Metabolism 2006
Shailendra Giri Ramandeep Rattan Ehtishamul Haq Mushfiquddin Khan Rifat Yasmin Je-song Won Lyndon Key Avtar K Singh Inderjit Singh

BACKGROUND Obesity is one of the principal causative factors involved in the development of metabolic syndrome. AMP-activated protein kinase (AMPK) is an energy sensor that regulates cellular metabolism. The role of AMP-activated protein kinase in adipocyte differentiation is not completely understood, therefore, we examined the effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (...

2016
Mun-Gyu Song Hye-Jin Lee Bo-Yeong Jin Ruth Gutierrez-Aguilar Kyung-Ho Shin Sang-Hyun Choi Sung Hee Um Dong-Hoon Kim

OBJECTIVE Adipose tissue (AT) expansion requires AT remodeling, which depends on AT angiogenesis. Modulation of AT angiogenesis could have therapeutic promise for the treatment of obesity. However, it is unclear how the capacity of angiogenesis in each adipose depot is affected by over-nutrition. Therefore, we investigated the angiogenic capacity (AC) of subcutaneous and visceral fats in lean a...

2014
Bilal A. Omar Giovanni Pacini Bo Ahrén

Insulin sensitivity declines in overweight and obese individuals and, under normal conditions, insulin secretion adaptively increases which in healthy non-diabetic subjects maintains normal glycemia. This adaptation is best described by the disposition index derived from modeling of insulin and glucose data from an intravenous glucose tolerance testing (IVGTT). One caveat of the IVGTT is that b...

Journal: :Diabetes technology & therapeutics 2013
Viswanathan Mohan Anandakumar Amutha Harish Ranjani Ranjit Unnikrishnan Manjula Datta Ranjit Mohan Anjana Lisa Staimez Mohammed K Ali K M Venkat Narayan

AIM This study examined β-cell function and insulin resistance (homeostasis model assessment-insulin resistance [HOMA-IR]) in Asian Indian youth with type 2 diabetes mellitus (T2DM-Y) and prediabetes. SUBJECTS AND METHODS Eighty-two subjects with non-insulin-requiring type 2 diabetes and age of onset below 25 years were recruited within 18 months of diagnosis and compared with age- and sex-ma...

2015
Yasuhito Shimada Shisei Kuninaga Michiko Ariyoshi Beibei Zhang Yasuhiko Shiina Yoshinori Takahashi Noriko Umemoto Yuhei Nishimura Hiroyuki Enari Toshio Tanaka

BACKGROUND Diet-induced hepatic steatosis is highly associated with nonalcoholic fatty liver disease, which is related to the development of metabolic syndrome. While advanced stage nonalcoholic hepatic steatosis and steatohepatitis (NASH) result ultimately in fibrosis and cirrhosis, the molecular basis for lipid droplet formation is poorly understood. Common pathways underlie the pathology of ...

Journal: :Endocrinology 2007
Gita L Rahardjo Xu-Feng Huang Yean Yeow Tan Chao Deng

It is well known that the peripheral peptide YY (PYY)-central neuropeptide Y (NPY) Y2 receptor axis plays an important role in promoting negative energy balance regulation. Both the hypothalamus and medulla oblongata express a high level of Y2 receptors; however, the functional role of this receptor in chronic high-fat diet-induced obesity has not been fully examined. Using quantitative autorad...

Journal: :Neuroendocrinology 2009
Lisa M Davis Michael Michaelides Lawrence J Cheskin Timothy H Moran Susan Aja Paul A Watkins Zhengtong Pei Carlo Contoreggi Karen McCullough Bruce Hope Gene Jack Wang Nora D Volkow Panayotis K Thanos

BACKGROUND The dopamine (DA) D(2) receptor (D2R) agonist bromocriptine (BC) decreases body fat in animal and human models and increases lean muscle mass, improves glucose intolerance and insulin resistance, and reduces triglycerides and free fatty acids. We have previously shown a negative correlation between D2R and body weight in obese individuals and in rodents, and that chronic food restric...

2016
Anne Kammel Sophie Saussenthaler Markus Jähnert Wenke Jonas Laura Stirm Andreas Hoeflich Harald Staiger Andreas Fritsche Hans-Ulrich Häring Hans-Georg Joost Annette Schürmann Robert W. Schwenk

Obesity and ectopic fat disposition are risk factors for metabolic disease. Recent data indicate that IGFBP2 expression in liver is epigenetically inhibited during hepatic steatosis. The aim of this study was to investigate if epigenetic de-regulation of hepatic Igfbp2 occurs already early in life and is associated with increased risk for diet-induced obesity (DIO) during adolescence. Male C57B...

2013
Anca D. Dobrian Elena V. Galkina Qian Ma Margaret Hatcher Sabai Myo Aye Mathew J. Butcher Kaiwen Ma Bronson A. Haynes Mark H. Kaplan Jerry L. Nadler

Signal transducer and activator of transcription (STAT) 4 is one of the seven members of the STAT family. STAT4 has a prominent role in mediating interleukin-12-induced T-helper cell type 1 lineage differentiation. T cells are key players in the maintenance of adipose tissue (AT) inflammation. The role of STAT4 in obesity and AT inflammation is unknown. We sought to determine the role of STAT4 ...

2009
Alessandro Pocai Paul E. Carrington Jennifer R. Adams Michael Wright George Eiermann Lan Zhu Xiaobing Du Aleksandr Petrov Michael E. Lassman Guoqiang Jiang Franklin Liu Corey Miller Laurie M. Tota Gaochao Zhou Xiaoping Zhang Michael M. Sountis Alessia Santoprete Elena Capito' Gary G. Chicchi Nancy Thornberry Elisabetta Bianchi Antonello Pessi Donald J. Marsh Ranabir SinhaRoy

OBJECTIVE Oxyntomodulin (OXM) is a glucagon-like peptide 1 (GLP-1) receptor (GLP1R)/glucagon receptor (GCGR) dual agonist peptide that reduces body weight in obese subjects through increased energy expenditure and decreased energy intake. The metabolic effects of OXM have been attributed primarily to GLP1R agonism. We examined whether a long acting GLP1R/GCGR dual agonist peptide exerts metabol...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید